ArticleBiomedicines2025

Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis.

Abdulaziz Algethami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.